M&A Deal Summary |
|
|---|---|
| Date | 2012-11-28 |
| Target | Alterna |
| Sector | Medical Products |
| Buyer(s) | Moberg Pharma |
| Sellers(s) | Altaris |
| Deal Type | Add-on Acquisition |
| Deal Value | 133M SEK |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2006 |
| Sector | Medical Products |
| Employees | 9 |
| Revenue | 439M SEK (2018) |
Moberg Pharma is a Swedish pharmaceutical company with direct sales through its own sales organization in the US and sales through distributors in more than 35 countries. The company’s product portfolio includes topical products for the treatment of skin disorders and pain under the brands Kerasal®, Jointflex®, Kerasal Nail® and Kaprolac®. Kerasal Nail® (Nalox™ in many markets) is the leading product for the treatment of nail disorders in the Nordic market. Moberg Pharma was founded in 2006 and is based in Bromma, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 7 |
| Sector (Medical Products) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (New Jersey) | 1 of 4 |
| Country (United States) | 1 of 7 |
| Year (2012) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-06 |
Domeboro
Cedar Knolls, New Jersey, United States Domeboro is a provider of topical astringent used for relieving itch and minor skin irritations. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 10.0B USD |
| Size | Mega |
| Type | Sector Focused |
Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 24 |
| Sector (Medical Products) | 2 of 8 |
| Type (Add-on Acquisition) | 4 of 10 |
| State (New Jersey) | 1 of 2 |
| Country (United States) | 6 of 22 |
| Year (2012) | 2 of 2 |
| Size (of disclosed) | 8 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-08-15 |
U.S. HealthWorks
Valencia, California, United States U.S. HealthWorks is a provider of occupational healthcare services in the United States. The Company offers solutions for employers that are seeking to control workers’ compensation costs, minimize lost employee work time, maintain healthy workplaces and strengthen productivity. USHW also provides non-injury occupational health services including job-site analysis, drug and alcohol testing and employment-related physical examinations. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-02-27 |
Intralign Health
Scottsdale, Arizona, United States Intralign Health is a specialty healthcare services company offering an integrated suite of services to hospitals and health systems. Intralign’s orthopedic solutions provide data-driven efficiency tools, care-centered design processes and clinical support services to healthcare providers, enabling them to better control the economics and quality of major joint replacements. |
Buy | - |
